Search Medical Condition
Please enter condition
Please choose location
 

Hassleholm, Sweden Clinical Trials

A listing of Hassleholm, Sweden clinical trials actively recruiting patients volunteers.

RESULTS

Found (5) clinical trials

A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery

This study has 2 parts, dose escalation and dose-response evaluation, and will be conducted in participants undergoing primary unilateral elective Total Knee Replacement (TKR) surgery. Participants will participate in either Part 1 or Part 2 of study only. The study will be conducted in 3 phases: an up to 30-day ...

Phase

0.0 miles

Learn More »

Tenecteplase in Wake-up Ischaemic Stroke Trial

Background One in five strokes occur during sleep, but patients with "wake-up" stroke are not given thrombolytic therapy because time of stroke onset is unknown. On-going trials are testing alteplase, and use MRI techniques for selection of patients. Tenecteplase has many pharmacological advantages over alteplase: greater fibrin specificity, very rapid ...

Phase

0.0 miles

Learn More »

TIMING of Oral Anticoagulant Therapy in Acute Ischemic Stroke With Atrial Fibrillation

Oral anticoagulation therapy is well established and highly recommended for the prevention of recurrent ischemic stroke in patients with atrial fibrillation, but the optimal time point to start after an acute ischemic stroke is not known. The intervention in this study will be timing of treatment onset. The choice of ...

Phase N/A

0.0 miles

Learn More »

Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event

The purpose of this study is to assess the efficacy and safety of S 44819 in enhancing functional recovery after an ischemic stroke.

Phase

0.0 miles

Learn More »

Triathlon Partial Knee Replacement (PKR) Outcomes Study

The purpose of the study is to evaluate the Triathlon PKR Knee System and determine whether or not the success rate of this device is no worse than the reported success rate of similar devices.

Phase N/A

0.39 miles

Learn More »